155 related articles for article (PubMed ID: 33252418)
1. Pre-hospitalization proton pump inhibitor use and clinical outcomes in COVID-19.
Ramachandran P; Perisetti A; Gajendran M; Jean-Louis F; Bansal P; Dwivedi AK; Goyal H
Eur J Gastroenterol Hepatol; 2022 Feb; 34(2):137-141. PubMed ID: 33252418
[TBL] [Abstract][Full Text] [Related]
2. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching.
Lee SW; Ha EK; Yeniova AÖ; Moon SY; Kim SY; Koh HY; Yang JM; Jeong SJ; Moon SJ; Cho JY; Yoo IK; Yon DK
Gut; 2021 Jan; 70(1):76-84. PubMed ID: 32732368
[TBL] [Abstract][Full Text] [Related]
3. Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study.
Kim B; Jung JH; Han K; Kang S; Lee E; Chung H; Kim SG; Cho SJ
J Korean Med Sci; 2023 Apr; 38(13):e99. PubMed ID: 37012686
[TBL] [Abstract][Full Text] [Related]
4. Increased ACE2 Levels and Mortality Risk of Patients With COVID-19 on Proton Pump Inhibitor Therapy.
Liu JJ; Sloan ME; Owings AH; Figgins E; Gauthier J; Gharaibeh R; Robinson T; Williams H; Sindel CB; Backus F; Ayyalasomayajula K; Parker A; Senitko M; Abraham GE; Claggett B; Horwitz BH; Jobin C; Adelman RM; Diamond G; Glover SC
Am J Gastroenterol; 2021 Aug; 116(8):1638-1645. PubMed ID: 34047305
[TBL] [Abstract][Full Text] [Related]
5. Proton Pump Inhibitor Use Is Not Strongly Associated With SARS-CoV-2 Related Outcomes: A Nationwide Study and Meta-analysis.
Israelsen SB; Ernst MT; Lundh A; Lundbo LF; Sandholdt H; Hallas J; Benfield T
Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1845-1854.e6. PubMed ID: 33989790
[TBL] [Abstract][Full Text] [Related]
6. Use of proton pump inhibitors are associated with higher mortality in hospitalized patients with COVID-19.
Wu S; Jin Z; Peng C; Li D; Cheng Y; Zhu R; He J; Wu C
J Glob Health; 2022; 12():05005. PubMed ID: 35198150
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors use prior to COVID-19 hospitalization is associated with higher C
Lucijanic M; Busic N; Stojic J; Barisic-Jaman M; Zagorec N; Lazibat K; Pasaric A; Vrkljan Vuk A; Durlen I; Mitrovic J; Luksic I; Barsic B
Expert Opin Drug Saf; 2023; 22(12):1265-1270. PubMed ID: 37417704
[TBL] [Abstract][Full Text] [Related]
8. The Proton Pump Inhibitors Use and COVID-19 from Prior to Vaccination Perspective: A Review.
Ksiądzyna D; Szeląg A
Dig Dis; 2023; 41(3):513-521. PubMed ID: 36257287
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors and gastrointestinal symptoms among patients with COVID-19 infection.
Al-Momani H; Aolaymat I
Ann Med; 2024 Dec; 56(1):2355581. PubMed ID: 38823421
[TBL] [Abstract][Full Text] [Related]
10. Long-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19.
Yozgat A; Kasapoğlu B; Can G; Tanoğlu A; Sakin YS; Yalçın KS; Gürler M; Kaplan M; Kaban MG; Kırsoy M; Kara U; Kekilli M
Turk J Med Sci; 2021 Aug; 51(3):1675-1681. PubMed ID: 34110723
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitor therapy usage and associated hospitalization rates and critical care outcomes of COVID-19 patients.
Shupp B; Mehta SV; Chirayath S; Patel N; Aiad M; Sapin J; Stoltzfus J; Schneider Y
Sci Rep; 2022 May; 12(1):7596. PubMed ID: 35534666
[TBL] [Abstract][Full Text] [Related]
12. Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort study.
Park J; You SC; Cho J; Park CH; Shin WG; Park RW; In Seo S
BMC Pharmacol Toxicol; 2022 Jan; 23(1):9. PubMed ID: 35039078
[TBL] [Abstract][Full Text] [Related]
13. Does Proton Pump Inhibitor Use Lead to a Higher Risk of Coronavirus Disease 2019 Infection and Progression to Severe Disease? a Meta-analysis.
Yan C; Chen Y; Sun C; Ahmed MA; Bhan C; Guo Z; Yang H; Zuo Y; Yan Y; Hu L; Sun Y; Li Y; Zhou Q
Jpn J Infect Dis; 2022 Jan; 75(1):10-15. PubMed ID: 34053958
[TBL] [Abstract][Full Text] [Related]
14. Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a prospective, multicentre, controlled, randomized, double-blind trial.
Wehmeyer MH; Horvatits T; Buchholz A; Krause L; Walter S; Zapf A; Lohse AW; Kluwe J;
Trials; 2022 Apr; 23(1):302. PubMed ID: 35414106
[TBL] [Abstract][Full Text] [Related]
15. People exposed to proton-pump inhibitors shortly preceding COVID-19 diagnosis are not at an increased risk of subsequent hospitalizations and mortality: A nationwide matched cohort study.
Kodvanj I; Homolak J; Trkulja V
Br J Clin Pharmacol; 2023 Feb; 89(2):787-831. PubMed ID: 36094656
[TBL] [Abstract][Full Text] [Related]
16. Proton Pump Inhibitors, Kidney Damage, and Mortality: An Updated Narrative Review.
Edinoff AN; Wu NW; Parker K; Dudossat E; Linquest L; Flanagan CJ; Dharani A; Patel H; Willett O; Cornett EM; Kaye AM; Kaye AD
Adv Ther; 2023 Jun; 40(6):2693-2709. PubMed ID: 37140707
[TBL] [Abstract][Full Text] [Related]
17. The Association Between Proton Pump Inhibitors and COVID-19 is Confounded by Hyperglycemia in a Population-Based Study.
Shafrir A; Benson AA; Katz LH; Hershcovici T; Bitan M; Paltiel O; Calderon-Margalit R; Safadi R; Shauly-Aharonov M
Front Pharmacol; 2022; 13():791074. PubMed ID: 35185561
[No Abstract] [Full Text] [Related]
18. Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19?
Charpiat B; Bleyzac N; Tod M
Clin Drug Investig; 2020 Oct; 40(10):897-899. PubMed ID: 32779119
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitor on susceptibility to COVID-19 and its severity: a systematic review and meta-analysis.
Pranata R; Huang I; Lawrensia S; Henrina J; Lim MA; Lukito AA; Kuswardhani RAT; Wibawa IDN
Pharmacol Rep; 2021 Dec; 73(6):1642-1649. PubMed ID: 33840053
[TBL] [Abstract][Full Text] [Related]
20. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
